Sale!

Replica: Osimertinib for EGFRm NSCLC with Ex19Del or L858R

Original price was: $738.00.Current price is: $579.00.

Targeting NSCLC patients with EGFR Ex19Del or L858R mutations, 3rd generation irreversible EGFR-TKI, anti-CNS metastasis activity, oral,

SKU: SKU67EM9EAUK Category:
Guaranteed Safe Checkout

Targeting NSCLC patients with EGFR Ex19Del or L858R mutations, 3rd generation irreversible EGFR-TKI, anti-CNS metastasis activity, oral,

Reviews

There are no reviews yet.

Be the first to review “Replica: Osimertinib for EGFRm NSCLC with Ex19Del or L858R”

Your email address will not be published. Required fields are marked *

Scroll to Top